Cytotoxic effect of cisplatin with proteasome inhibitor on osteosarcoma cells / 浙江大学学报·医学版
Zhejiang Daxue xuebao. Yixue ban
; (6): 395-399, 2005.
Article
em Zh
| WPRIM
| ID: wpr-355196
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the cytotoxic effect of cisplatin with proteasome inhibitor on osteosarcoma cells.</p><p><b>METHODS</b>Cell survival was tested by MTT, apoptotic morphology was observed by electron microscopy, apoptotic rate was analyzed by flow cytometry, the transcription level of excision repair cross complementation-1 (ERCC-1) was tested by reverse transcription polymerase reaction.</p><p><b>RESULTS</b>Compared with cells treated with cisplatin alone, cells treated with cisplatin and proteasome inhibitor showed a decreased survival rate, more typical apoptotic morphology, higher apoptotic rate [(14.37 +/-2.37)% vs. (50.93 +/-4.84)%, P<0.01)], and lower transcription level of excision repair cross complementation-1.</p><p><b>CONCLUSION</b>Proteasome inhibitor could increase the cytotoxic effect of cisplatin on osteosarcoma cells and promote cisplatin-induced osteosarcoma apoptosis. These effects may be associated with the decreased transcription of excision repair cross complementation-1.</p>
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Oligopeptídeos
/
Patologia
/
Farmacologia
/
Neoplasias Ósseas
/
Células Tumorais Cultivadas
/
Osteossarcoma
/
Cisplatino
/
Apoptose
/
Sinergismo Farmacológico
/
Antineoplásicos
Limite:
Animals
Idioma:
Zh
Revista:
Zhejiang Daxue xuebao. Yixue ban
Ano de publicação:
2005
Tipo de documento:
Article